Status of the endothelium-derived hyperpolarizing factor pathway in coronary arteries after heterotopic heart transplantation

被引:7
|
作者
Perrault, Louis P.
Aubin, Marie-Claude
Malo, Olivier
Thollon, Catherine
Villeneuve, Nicole
Vilaine, Jean-Paul
Vanhoutte, Paul M.
机构
[1] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[2] Montreal Heart Inst, Dept Surg, Montreal, PQ H1T 1C8, Canada
[3] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[4] Inst Rech Servier, Div Cardiovasc, Neuilly Sur Seine, France
[5] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[6] Univ Hong Kong, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China
来源
关键词
D O I
10.1016/j.healun.2006.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: After the first year of transplantation, the major limitation to long-term survival is the development of graft coronary vasculopathy, characterized by a pathologic activation of the endothelium with an attendant loss of its regulatory properties on homeostasis of the vascular wall. The present study was designed to evaluate the integrity of coronary vascular relaxations attributed to the endothelium-derived hyperpolarizing factor (EDHF) and to study hyperpolarization of smooth muscle cells after heterotopic heart transplantation. Methods: Six weeks after heart transplantation in a porcine model, vascular reactivity studies of control, native and allograft epicardial coronary artery rings were performed in standard organ chamber experiments. Moreover, membrane potential measurements were made with intracellular microelectrodes in rings of native and allograft coronary arteries. Results: There was a significant decrease in endothelium-dependent relaxations to 5-hydroxytryptamine (5-HT), high doses of bradykinin (BK) alone and BK plus N-omega-nitro-L-arginine (L-NNA) in rings from allograft compared to native, whereas the variation was significantly increased in response to cromakalim, a K+-ATP channel opener. Electrical and mechanical recordings showed no alteration in the resting membrane potential of smooth muscle cells, depolarization during contraction to prostaglandin F-2 alpha (PGF(2 alpha)), or hyperpolarization in the presence of BK + L-NNA in rings of allograft vs native. Conclusions: In this swine model of heart transplantation, part of the reduction in endothelium-dependent relaxations to BK may be attributed to an alteration in the activity of EDHF. This impairment of EDHF-mediated relaxations may compound the endothelial dysfunction preceding the development of coronary graft vasculopathy.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 50 条
  • [1] INHIBITORY EFFECT OF ENDOTHELIUM IS MEDIATED BY ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR IN MOUSE CORONARY ARTERIES
    Enkhjargal, Budbazar
    Godo, Shigeo
    Noda, Kazuki
    Nakajima, Sota
    Shimokawa, Hiroaki
    JOURNAL OF VASCULAR RESEARCH, 2012, 49 : 15 - 15
  • [2] Importance of endothelium-derived hyperpolarizing factor in human arteries
    Shimokawa, H
    Urakami-Harasawa, L
    Nakashima, M
    Tagawa, H
    Hirooka, Y
    Takeshita, A
    ENDOTHELIUM-DEPENDENT HYPERPOLARIZATIONS, 1999, : 391 - 398
  • [3] The importance of endothelium-derived hyperpolarizing factor in human arteries
    Urakami, L
    Shimokawa, H
    Yasutake, H
    Nakashima, M
    CIRCULATION, 1996, 94 (08) : 3716 - 3716
  • [4] Importance of endothelium-derived hyperpolarizing factor in human arteries
    Urakami-Harasawa, L
    Shimokawa, H
    Nakashima, M
    Egashira, K
    Takeshita, A
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11): : 2793 - 2799
  • [5] A novel endothelium-derived hyperpolarizing factor from docosanoic acid in coronary arteries
    Li, VX
    Teggatz, EG
    Gauthier, KM
    Serhan, CN
    Campbell, WB
    Li, PL
    HYPERTENSION, 2004, 44 (04) : 540 - 540
  • [6] An evaluation of potassium ions as endothelium-derived hyperpolarizing factor in porcine coronary arteries
    Bény, JL
    Schaad, O
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (05) : 965 - 973
  • [7] Endothelium-derived hyperpolarizing factor
    Félétou, M
    Vanhoutte, PM
    DRUG NEWS & PERSPECTIVES, 1999, 12 (04) : 217 - 222
  • [8] Endothelium-derived hyperpolarizing factor
    Shu Fang Liu
    Respiratory Research, 2 (1)
  • [9] Endothelium-derived hyperpolarizing factor
    Feletou, M
    Vanhoutte, PM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (12): : 1082 - 1090
  • [10] ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR
    KOMORI, K
    VANHOUTTE, PM
    BLOOD VESSELS, 1990, 27 (2-5): : 238 - 245